CI Investments Inc. Reduces Stock Position in Cigna Group $CI

CI Investments Inc. decreased its position in shares of Cigna Group (NYSE:CI) by 26.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,802 shares of the health services provider’s stock after selling 5,998 shares during the quarter. CI Investments Inc.’s holdings in Cigna Group were worth $4,843,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA grew its holdings in Cigna Group by 1.1% in the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after purchasing an additional 123,479 shares during the last quarter. Dodge & Cox boosted its position in shares of Cigna Group by 0.7% in the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock worth $2,958,893,000 after buying an additional 60,877 shares in the last quarter. Norges Bank acquired a new stake in Cigna Group in the 2nd quarter valued at about $1,110,426,000. Arrowstreet Capital Limited Partnership increased its holdings in Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after acquiring an additional 492,045 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Cigna Group by 0.7% during the second quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock worth $678,652,000 after acquiring an additional 15,014 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CI has been the topic of several research reports. Mizuho set a $325.00 price target on shares of Cigna Group in a research report on Friday, January 9th. Deutsche Bank Aktiengesellschaft increased their target price on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a report on Tuesday, February 10th. Guggenheim reissued a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. Finally, Jefferies Financial Group lifted their price objective on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $330.42.

Cigna Group Price Performance

Shares of NYSE:CI opened at $284.50 on Thursday. The business has a fifty day simple moving average of $280.68 and a 200-day simple moving average of $284.45. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a market cap of $74.97 billion, a P/E ratio of 12.83, a P/E/G ratio of 0.98 and a beta of 0.27. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same period last year, the company earned $6.64 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is 27.23%.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by company insiders.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna’s credit ratings were affirmed by AM Best (Financial Strength Rating A / Long‑Term ICR “a+”), which reduces balance‑sheet and counterparty concerns for investors. AM Best affirms ratings
• Positive Sentiment: Major sell‑side support remains: Piper Sandler kept an Overweight stance and high price target (small trim), and other analysts continue to highlight Cigna’s growth profile after strong earnings. That provides continued analyst backing for the stock. Piper Sandler price target story
• Positive Sentiment: Cigna reaffirmed its 2026 financial outlook while announcing the CEO succession and elected Brian Evanko to the board — the outlook reaffirmation reduces immediate guidance risk. PR Newswire release
• Positive Sentiment: Cigna raised its quarterly dividend (announced recently), which supports income investors and signals management confidence in cash flow. MarketBeat dividend note
• Neutral Sentiment: Management appearances and investor conference activity (TD Cowen) plus regional PR (awards, interviews) provide investor color but are not immediate stock catalysts. TD Cowen presentation notice
• Neutral Sentiment: Profile/interview pieces on outgoing CEO David Cordani and the company’s long-term strategy add context for investors but are informational rather than catalytic. Courant CEO profile
• Negative Sentiment: The CEO succession (David Cordani to retire July 1; President/COO Brian Evanko to succeed) prompted an initial negative market reaction as investors digested leadership change and execution risk, which was the primary near‑term drag on the stock. Seeking Alpha on leadership transition
• Negative Sentiment: Insider selling (recent filings show officers/directors trimming positions) can amplify near‑term downward pressure or signal liquidity needs; monitor whether sales continue. InsiderTrades alert
• Negative Sentiment: Broader healthcare sector weakness this week is a headwind for CI — sector declines can depress even well‑funded insurers in the short term. Yahoo sector update

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.